Lisa M. Dietz

Bunsen Kirchhoff Str. 11
Dortmund, NW 44139, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis.

Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis.

Journal: British journal of pharmacology
Published: November 24, 2025

sGC stimulator BAY 41-8543 improves survival and ventricular function in a rat model of doxorubicin-induced cardiomyopathy with nephrotic syndrome.

sGC stimulator BAY 41-8543 improves survival and ventricular function in a rat model of doxorubicin-induced cardiomyopathy with nephrotic syndrome.

Journal: British journal of pharmacology
Published: October 30, 2025

Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation.

Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation.

Journal: Nature cardiovascular research
Published: July 24, 2023

Activating soluble guanylyl cyclase attenuates ischemic kidney damage.

Activating soluble guanylyl cyclase attenuates ischemic kidney damage.

Journal: Kidney international
Published: June 19, 2023

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase.

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase.

Journal: Frontiers in cardiovascular medicine
Published: May 10, 2023

Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis.

Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis.

Journal: Bioanalysis
Published: September 20, 2022

A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy.

A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy.

Journal: Bioconjugate chemistry
Published: June 06, 2022

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.

Journal: Respiratory research
Published: May 06, 2022

Applying context of use to quantitative polymerase chain reaction method validation and analysis: a recommendation from the European Bioanalysis Forum.

Applying context of use to quantitative polymerase chain reaction method validation and analysis: a recommendation from the European Bioanalysis Forum.

Journal: Bioanalysis
Published: October 28, 2021

The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms.

The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms.

Journal: Scientific reports
Published: October 04, 2021

Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.

Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.

Journal: International journal of molecular sciences
Published: April 29, 2021

Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042).

Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042).

Journal: Journal of medicinal chemistry
Published: April 19, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026